Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 8/20 | 0.68 |
| ▸ | MAPT | P10636 | 12/20 | 0.64 |
| ▸ | RAB9A | P51151 | 7/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.62 |
| ▸ | HTT | P42858 | 3/20 | 0.61 |
| ▸ | GAA | P10253 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 5/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23678214 | 1.00 | SMN1; SMN2 (0.68) | SMN1; SMN2MAPTRAB9AALDH1A1HTT | |
| SCHEMBL20205856 | 0.91 | GAA (0.72) | SMN1; SMN2MAPTRAB9AALDH1A1HTT | |
| SCHEMBL4554299 | 0.85 | SMN1; SMN2 (0.67) | SMN1; SMN2MAPTRAB9AALDH1A1HTT | |
| SCHEMBL20205929 | 0.81 | MAPT (0.54) | SMN1; SMN2MAPTRAB9AALDH1A1HTT | |
| SCHEMBL23678475 | 0.81 | MAPT (0.54) | SMN1; SMN2MAPTRAB9AALDH1A1HTT | |
| SCHEMBL14938579 | 0.80 | SMN1; SMN2 (0.69) | SMN1; SMN2MAPTRAB9AALDH1A1HTT | |
| SCHEMBL24199547 | 0.80 | MAPT (0.52) | SMN1; SMN2MAPTRAB9AALDH1A1HTT | |
| SCHEMBL20205543 | 0.80 | MAPT (0.52) | SMN1; SMN2MAPTRAB9AALDH1A1HTT | |
| SCHEMBL23678344 | 0.79 | MAPT (0.68) | SMN1; SMN2MAPTRAB9AALDH1A1HTT | |
| SCHEMBL20205809 | 0.79 | MAPT (0.68) | SMN1; SMN2MAPTRAB9AALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11225470-B2 | Tetrazolinone compounds and its use as pest control agents | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-01-18 | — | — | US | disclosed |
| EP-3544973-B1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PEST CONTROL AGENTS | SUMITOMO CHEMICAL CO (JP) | 2021-07-28 | — | — | EP | disclosed |
| WO-2018097318-A1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PEST CONTROL AGENTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11225470-B2 | Tetrazolinone compounds and its use as pest control agents | CYC1, MT-CO1, CTRL | SMN1; SMN2 2001/4885MAPT 3767/4885RAB9A 3323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.